The impact of vitamin K-dependent factor depletion by warfarin on platelet-rich thrombosis after deep arterial injury.
McBane
R D
RD
Division of Cardiovascular Medicine, Mayo Clinic and Foundation for Eduaction and Research, Rochester, Minnesota 55905, USA. mcbane.robert@mayo.edu
Hassinger
N L
NL
Grill
D E
DE
Chesebro
J H
JH
D017130:Angioplasty / Q000009:adverse effects; D000818:Animals; D001158:Arteries / Q000293:injuries*; D001241:Aspirin / Q000627:therapeutic use; D001779:Blood Coagulation Factors / Q000037:antagonists & inhibitors* / Q000378:metabolism; D001792:Blood Platelets / Q000473:pathology; D004305:Dose-Response Relationship, Drug; D005340:Fibrinogen / Q000378:metabolism; D019934:International Normalized Ratio; D010973:Platelet Adhesiveness; D013552:Swine; D013927:Thrombosis / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*; D014812:Vitamin K; D014859:Warfarin / Q000008:administration & dosage / Q000494:pharmacology*
D001779:Blood Coagulation Factors; D014812:Vitamin K; D014859:Warfarin; D005340:Fibrinogen; D001241:Aspirin